Search

everythinglearnresearchcommunity

for

Search:↓

Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.

COVID-19 can cause hair loss, but specialists can help treat it.

Finasteride is more effective and satisfactory than montelukast for treating moderate acne in women.

Certain inflammatory factors may increase or decrease the risk of developing PCOS.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Heavy metals might contribute to hair loss in Telogen Effluvium.

Nanocarriers show promise for improving skin drug delivery in treating skin conditions.

The woman delivered a healthy baby boy despite taking spironolactone during pregnancy.

Stopping birth control pills may have triggered a manic episode in a woman with HAIR-AN syndrome.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Flutamide helps with prostate cancer and some skin conditions but can harm the liver.

Common skin conditions can greatly affect a person's mental health and social life.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Women with PCOS may have a higher risk of Alzheimer's disease.

Women with PCOS are more likely to have depression and anxiety.

Nutraceutical insulin-sensitizing agents may help treat skin conditions like psoriasis and acne.

Benign conditions can mimic serious ones in postmenopausal hyperandrogenism, requiring careful diagnosis.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Higher levels of the protein Pannexin-1 may play a role in hair loss in women with PCOS.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Balding men had lower bone density, while balding women had higher hip bone density.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.